The American College of Cardiology's 68th Annual Scientific Session & Expo (ACC.19) offered a robust grouping of late-breaking clinical trials, from the extensive and favorable evolution of mitral and aortic valve therapies to the latest on extending the timing and optimal combinations of antiplatelet strategies to ensure maximum simplicity, efficacy, and safety.
↧